SecA is an essential component in the Sec-dependent protein translocation pathway and, together with ATP, provides the driving force for the transport of secretory proteins across the cytoplasmic membrane of Escherichia coli. Previous studies established that SecA undergoes monomer-dimer equilibrium in solution. However, the oligomeric state of functional SecA during the protein translocation process is controversial. In this study, we provide additional evidence that SecA functions as a dimer in the membrane by (i) demonstration of the capability of the presumably monomeric SecA derivative to be cross-linked as dimers in vitro and in vivo, (ii) complementation of the growth of a secA(Ts) mutant with another nonfunctional SecA or (iii) in vivo complementation and in vitro function of a genetically tandem SecA dimer that does not dissociate into monomers, and (iv) formation of similar ring-like structures by the tandem SecA dimer and SecA in the presence of lipid bilayers. We conclude that SecA functions as a dimer in the membrane and dissociation into monomers is not necessary during protein translocation.
The Sec-dependent protein translocation pathway is responsible for the majority of protein exportation in bacteria. SecA is an essential and ubiquitous component (4, 21) and, together with ATP, provides the driving force for the transport of secretory proteins across the cytoplasmic membrane of Escherichia coli (20) .
The structure of SecA in solution has been studied extensively. SecA has been previously described as a homodimer of 102-kDa subunits that undergoes monomer-dimer equilibrium in solution (1, 8, 32) . However, the structure of SecA in the membrane is not well understood and the oligomeric state of functional SecA in the membrane is controversial. Or et al. (23) advocated that SecA functions as a monomer in protein translocation on the basis of evidence that acidic phospholipids and a synthetic signal peptide induce dissociation of SecA dimers. Later, Benach et al. (3) reported that monomeric SecA is the transient stage of SecA as signal peptides redimerize it during preprotein translocation, concluding that functional SecA is a dimer. Similar results were also reported by Shin et al. (29) , who found that signal peptides induce SecA oligomerization and consequently enhance its ability for membrane insertion. A more recent study by Alami et al. using Nanodiscs, an emerging technology, showed that the SecYEG complex triggers dissociation of the SecA dimer; however, no evidence was shown that the Nanodisc-reconstituted SecYEG monomer was active in protein translocation (2) .
Or et al. (22) generated a reported monomeric SecA derivative mutant, SecA⌬11/N95, which lacks extreme terminal residues and showed in vitro and in vivo activities, suggesting that functional SecA is a monomer. Contradictory results have been reported for a similar SecA monomer, SecA⌬11, in which no in vivo or in vitro activities were detected (14) , indicating that the SecA dimer is the functional unit of protein translocation (13, 14, 25, 27) . Interestingly, however, a recombinant SecA protein (amino acids 9 to 861, lacking both the N and C termini) from E. coli was recently crystallized as an antiparallel dimer at 2 Å resolution, revealing that neither the N nor the C terminus, as previously reported (15) , is related to dimerization (25) . Or et al. (24) showed that a disulfide-cross-linked SecA dimer is inactive, suggesting that dissociation of SecA dimers into monomers is required during protein translocation. However, a similar cross-linked SecA-Cys637/801 dimer retained its in vitro activity (13) . In addition, a nondissociable SecA dimer, crossed-linked at its C terminus, is functional in protein translocation in vitro, demonstrating that dissociation of the SecA dimer is not an essential step in preprotein translocation (6) .
In the present work, we first determined the oligomeric state of the proposed monomeric SecA⌬11/N95 protein by various means and showed its ability to form dimers. In addition, we demonstrated that combination of two nonfunctional SecA molecules leads to activity. Furthermore, we generated genetically a nondissociable SecA tandem dimer and showed its full functionality in vivo and in vitro. Moreover, the structure of the tandem SecA dimer in the membrane is strikingly similar to that of wild-type SecA, as observed by atomic force microscopy (AFM). Together, our results further support the ideas that functional SecA is a dimer in the membrane and that dissociation into monomer form is not an essential step in vivo or in vitro for SecA to function in protein translocation.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. E. coli DH5␣ was used for plasmid isolation and for subcloning of DNA fragments. E. coli BL21.19 (18) harboring pET5a/secA⌬11/N95 or pET5a/secAA was used for complementation assays, and BL21(DE3) was used for overproduction of SecA derivatives. Cells for SecA derivative overproduction were cultured in TAG medium (10 g/liter tryptone, 5 g/liter NaCl, A salts [30] , 0.5% glucose) supplemented with 100 g/ml ampicillin. E. coli MM52 (recA) was obtained from D. Oliver (28) . To construct pET5a/ secA⌬11/N95, the N-terminal NdeI/EcoRI fragment of pET5a/secA/N95 (laboratory stock; unpublished data) was replaced with a PCR product, the corresponding fragment of 411 bp amplified from pET5a/secA⌬2-12 (laboratory stock; unpublished data) with the SecA 11th amino acid inserted after the first codon, treated with the same enzymes. To construct pET5a/secA826, the KpnI/SnaBI fragment of pET5a/secA was replaced with a PCR fragment that was amplified with 5Ј primer 5Ј GGCCTGCATATCATCGGTACC3Ј and 3Ј primer 5ЈTTAT TACAGCGTACTGATAACTTCATA3Ј and introduced with two consecutive stop codons, followed by blunt-end ligation. In this construction, pET5a/secA was used as the template and Pfu DNA polymerase (Stratagene) was used to generate the blunt-end PCR fragment. The resulting PCR fragment was then digested with KpnI alone and swapped with the KpnI/SnaBI fragment of secA located between bp 1676 and 2478. pET5a/secAL826Q was generated in a similar manner, except that site-directed mutagenesis was introduced by a three-round asymmetric PCR method (33) to obtain the desired point mutation. pET5a/ secAA was constructed from pET5a/secA. The entire PCR-amplified secA gene was inserted into the NdeI site of pET5a/secA treated with the same restriction enzyme to yield pET5a/secAA without a linker. All of the plasmid constructions were verified at the DNA Sequencing Core Facility (Department of Biology, Georgia State University).
Expression and purification of SecAA or SecA⌬11/N95. All protein purification steps and centrifugations were performed at 4°C. SecA⌬11/N95-and SecAA-overexpressing cells were cultured at 30°C to an optical density at 600 nm (OD 600 ) of 0.8 and induced with 0.5 mM isopropyl-␤-D-thiogalactopyranoside (IPTG). Proteins were overexpressed at 20°C for 16 h or at 30°C for 4 h. Cells were harvested by centrifugation in a Beckman JA-10 rotor at 5,000 rpm for 15 min and resuspended in 2 ml/g wet cells of TKMD buffer (10 mM Tris-acetate, pH 7.6, 50 mM KCl, 10 mM Mg acetate, 1 mM dithiothreitol [DTT]). Protease inhibitor cocktail (Roche) was added before cell suspensions were passed through a French pressure cell (SLM-Aminco) at 15,000 lb/in 2 . Cell lysates were centrifuged at 30,000 rpm for 60 min with a Beckman TLA-100.3 rotor to remove membranes and debris. After centrifugation to remove any aggregates, the supernatant was diluted five times with PPB buffer (25 mM sodium phosphate, pH 7.6, 1 mM DTT) and then loaded onto a Q-Sepharose 26/10 (Amersham Bioscience Corp.) anion-exchange column. SecAA was eluted at about 0.4 M NaCl. Fractions containing SecAA detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were pooled and concentrated by a centrifugal filter device with a cutoff of 30 kDa (Amicon). The recovered supernatant fraction was diluted five times with PPB buffer (25 mM sodium phosphate, pH 6.4, 1 mM DTT) and then applied to an SP-Sepharose 16/5 (Amersham Bioscience Corp.) cation-exchange column. SecAA was eluted at about 0.39 M NaCl. Fractions containing SecAA detected by SDS-PAGE were pooled and concentrated by the same centrifugal filter device to a volume of 0.5 ml and loaded onto a Superose 12 HR gel filtration column (Amersham Bioscience Corp.) and eluted in 100 mM (NH 4 )HCO 3 buffer containing 1 mM DTT at a flow rate of 0.5 ml/min. Fractions that contained SecAA were combined, aliquoted, and stored at Ϫ80°C. SecA⌬11/N95 was purified similarly with only two chromatography steps, without the Q-Sepharose column step. SecA⌬11/N95 was eluted from an SP-Sepharose column at 0.34 M NaCl. Protein concentration was determined by the Bradford assay (Bio-Rad) with bovine serum albumin as the standard.
Cross-linking assay. In vitro cross-linking was conducted with 1 mM EDC [1-ethyl-3-(3-dimethyl-aminopropyl)carbodiimide; Sigma] in 0.1 M MES buffer, pH 6.4, at room temperature for the indicated times. In vivo cross-linking was performed with 0.1 or 1% formaldehyde (HCHO; Sigma Chemical Co.) as previously described (17) . Cross-linked products were analyzed by SDS-PAGE, followed by immunoblotting with rabbit SecA antibody.
Complementation assay. Overnight-growing BL21.19 or MM52(recA) cells harboring vector pET5a alone or the indicated SecA derivatives were cultured in fresh LB/Amp at 30°C. Cells were adjusted to the same OD 600 of 0.5. For the LB/Amp plate assay, 1 l of each indicated dilution was spotted onto the plate and incubated at 42°C. A duplicate control plate was incubated at 30°C. For the CFU assay (26) , 50-to 100-l volumes of serial 10-fold dilutions were applied to plates prepared from the same medium and incubated at 42°C. Duplicate control plates were incubated at 30°C. Plates containing 30 to 300 colonies were used for plating efficiency counts.
ATPase activity assays. ATPase activity assays were carried out as previously reported (16) . Liposomes were prepared from E. coli total-lipid mixtures (Avanti Polar Lipids, Inc.) by sonication in a water bath.
In vitro protein translocation assay. Protein translocations were carried out as previously described (5), with SecA-depleted BA13 membrane vesicles (4). Protein synthesis was performed with an S30 extract of SecA-depleted BL15.5 as previously described (4). The messenger was total RNA from strain HJM114 containing plasmids pOmp9 and pCI857 (9) . The membrane vesicles containing the 35 S-labeled proteins after proteinase K treatment were isolated, analyzed by 12% SDS-PAGE, autoradiographed, and quantified with a densitometer. The amount of 35 S-labeled pro-OmpA used in the translocation assay was defined as 100%. The results shown are averages from four separated experiments.
AFM. AFM images were obtained with a CP-Autoprobe (Park Scientific, Sunnyvale, CA) by using the noncontact mode as previously described (31) .
RESULTS AND DISCUSSION
Functional SecA⌬11/N95 is a dimer. As part of our ongoing studies of the roles of the N and C termini of SecA, we constructed a SecA⌬11/N95 derivative identical to that of Or et al. (22) and confirmed its activities in vivo by growth complementation by a CFU assay as previously described (26) . Consistent with the previous reports (13, 14, 22) , SecA⌬11/N95 was able to complement secA(Ts) amber mutant strain BL21.19 to the same extent as wild-type SecA (18) at the nonpermissive temperature (Fig. 1A) . In addition, we purified the truncated SecA protein and examined its oligomeric state by cross-linking with the zero-length cross-linker EDC and size exclusion chromatography. In contrast to the previous finding of monomers without detectable dimers (22), we found that SecA⌬11/N95 showed strong dimer-oligomer (indicated by brackets) crosslinking (Fig. 1B) .
This discrepancy could possibly be due to different salt concentrations in the reaction buffers, to which SecA monomerdimer equilibrium is sensitive (32). Benach et al. (3) also pointed out that the behavior of SecA could be altered in different cross-linking buffers. The exact physiological ionic strength and SecA concentration where the translocations take place remain to be determined; however, in vitro protein translocation activity was inhibited at an approximately physiological ionic strength of 150 mM NaCl (5). We therefore conducted direct cross-linking in vivo (17) by adding 0.1% formaldehyde to pETsecA⌬11/N95/BL21.19 intact cells grown at 42°C. Again, SecA⌬11/N95 was able to cross-link under physiological conditions, as dimers and/or higher-order oligomers were observed in a pattern similar to that produced by in vitro cross-linking with purified SecA⌬11/N95. Formaldehyde-dependent cross-linking of products (indicated by the asterisk) was observed as generated in vitro (Fig. 1C, lanes 2  and 5) , and the cross-linked products were readily reversed upon heating (lanes 3 and 6), indicating that those complexes represented dimeric (and/or higher-order) forms of this particular construct. This result is in contrast to the report by Or et al. (22) showing that double-cysteine-mutated SecA⌬11/N95 remained in monomeric form in vivo.
Next, we examined the oligomeric state of SecA⌬11/N95 in parallel with SecA by size exclusion chromatography with an approximately physiological ionic strength buffer (150 mM NaCl, 20 mM sodium phosphate buffer, pH 7.0, 1 mM DTT). In agreement with previous observations (32) , our data show that both SecA⌬11/N95 and SecA were equally sensitive to salt and protein concentrations (data not shown). At low protein and high salt concentrations, as described above, SecA⌬11/ N95 and SecA (4 to 5 M) eluted at the same volume as a monomer, whereas in a lower-ionic-strength buffer [100 mM (NH 4 )HCO 3 ], SecA⌬11/N95 eluted earlier with an estimated molecular mass of 158 kDa, indicating an equilibrium shift toward dimers (data not shown). The cellular concentration of SecA was reported to be 8 M (1), which is higher than the concentration in our assay. Additionally, increased temperatures favor dimer formation (32); however, we observed dimer formation even at 4°C. Together, our data show that dimer formation by SecA⌬11/N95 and SecA in vitro was similar. The results were further supported by those of Gold et al., which predicted that monomeric mutant SecA⌬11/N95 is a dimer as illustrated by equilibrium and velocity analysis by analytical ultracentrifugation (10) . Taken together, our in vivo and in vitro cross-linking results strongly support the conclusion that the presumably monomeric SecA derivative in fact functions as a dimer.
Though our results are contradictory to the findings reported by Or et al. (22, 23) , it is not surprising that SecA⌬11/ N95 could be dimerized since N95 was reported to be a dimer and the C-terminal domain of SecA (residues 662 to 831), but not the N-terminal region, was reported to be essential for SecA dimerization (11) . Furthermore, a recent report based on crystal structures of the recombinant E. coli SecA (amino acids 9 to 861) homodimer indicates that dimerization is mediated solely through extensive contacts of the DEAD motor domain but not the C or N terminus (25) .
A defective SecA protein complemented the growth of MM52 [secA51(Ts)/recA]. Another line of evidence that SecA may function as a dimer came from complementation studies with two defective SecA mutants, i.e., well-known temperature-sensitive point mutant MM52 (28) and secA(Ts) amber mutant BL21.19 (18) . In our study of the function of C-terminal SecA, we constructed SecA826 containing a deletion of the C-terminal 76 amino acids and a derivative, SecAL826Q, with an additional point mutation at amino acid 826. SecA826 was able at 42°C. SecA⌬11/N95 could be cross-linked as a dimer in vitro (B) and in vivo (C). Purified SecA⌬11/N95 and SecA were subjected to EDC cross-linking as described in Materials and Methods (B). (C) Cross-linking by HCHO. BL21.19 harboring pETsecA⌬11/N95 was first grown at 30°C in LB containing 100 g/ml ampicillin until the OD reached 1.0; cells were then diluted 10-fold in fresh medium and further cultured at 42°C to an OD 600 of 1.2. Cells were harvested by centrifugation, and in vivo cross-linking was performed as previously described (17) . Purified SecA⌬11/ N95 protein was used as the control. Samples were analyzed by 5% (EDC cross-linking) or 10% (HCHO cross-linking) SDS-PAGE and detected by Western blotting with anti-SecA serum.
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on October 23, 2017 by guest http://jb.asm.org/ to complement secA(Ts) amber mutant BL21.19 at 42°C, whereas its derivative SecAL826Q, with the last hydrophobic amino acid residue replaced with a polar residue, was not ( Fig.  2A) , indicating that SecAL826Q is not functional. However, SecAL826Q restored the growth of MM52 [secA51(Ts)], which contains a nonfunctional point mutation, SecAL43P (28), at 42°C ( Fig. 2A) .
To exclude the possibility of homologous recombination, a recA derivative of MM52 (a gift kindly provided by D. Oliver) transformed with pET5a/secAL826Q was tested by the CFU assay. The data showed complementation of growth at 42°C (Fig. 2B ) with a plating efficiency that was 28% of that at 30°C. These results indicate that combination of two inactive SecA molecules, presumably forming heterodimers, leads to complementation activity. To test whether the two inactive SecA molecules form oligomers, in vivo cross-linking was carried out with the contact site cross-linker formaldehyde. As expected, cross-linking of SecAL43P and SecAL826Q with 1% formaldehyde was observed (Fig. 2C, lane 9 , indicated by the asterisk). Since the amount of SecAL826Q in the cells is significantly less than that of SecAL43P, it is conceivable that little SecAL826Q was cross-linked at a lower concentration of formaldehyde (lane 7). This could explain the low plating efficiency (28%) of MM52/pET5a/secAL826Q at 42°C. The specificity of cross-linked products was also verified by reduction by heating as described above (lane 10).
The complementation result indicates that monomeric SecA is not active, which is in agreement with previous reports (7, 8, 12, 14, 32) . There are at least two possible mechanisms by which a defective SecA protein (SecAL826Q) complements the growth of MM52 (SecAL43P), (i) heterodimer formation from two nonfunctional SecA molecules and (ii) reassembly of functional monomeric SecA from functional domains provided by the two nonfunctional SecA variants. Although the complementation experiment cannot discriminate between the two possibilities, our other data suggest that functional SecA is mostly dimeric. Therefore, the latter is less likely to happen. In addition, E. coli SecA has been crystallized as a dimer and the dimeric form was proposed to facilitate its catalytic activity by a hand-over-hand mechanism for preprotein chain relay (25) . Our results strongly suggest that heterodimeric SecA consisting of two inactive variants, not a monomer, is functional in the membrane.
Genetically dimerized SecA is functional in vivo and in vitro. To provide additional direct evidence that SecA dimers are indeed functional in vivo, we constructed plasmid pET5a/ secAA containing wild-type secA genes in tandem, without linkers in between, to yield head-to-tail tandem SecA dimers. The genetically linked SecA dimers fully complemented secA(Ts) amber mutant BL21.19 at the nonpermissive temperature in the presence of the protease inhibitor phenylmethylsulfonyl fluoride to prevent the cleavage of dimeric SecAA (Fig. 3A) , with a plating efficiency of 92.5% of that at 30°C. The dimeric SecAA protein was stable, as the cells at 42°C lacked detectable monomeric SecA (Fig. 3B) . Furthermore, the purified tandem SecA dimers (with a molecular mass of about 202 kDa and Ͼ97% purity, as analyzed by SDS-PAGE; Fig. 4A ) were fully functional (Fig. 4) , as shown below.
The intrinsic ATPase activity of tandem SecAA dimers, like SecA, was low, as previously reported (19) , and the activity was also stimulated by liposomes to a level similar to that of wildtype SecA (Fig. 4B and C) . Moreover, the in vitro translocation activity of purified SecAA (Fig. 4D ) was significantly higher than that of the proposed monomeric SecA mutant (22) and similar to that of the reported conjugated SecA dimer which no longer supports SecB-dependent protein translocation (6). The inactive cross-linked dimers reported by Or et al. (24) were most likely due to loss of other dynamic features of SecA in the protein translocation process. Our observations of fully active tandem SecAA suggest that the head-to-tail SecA dimers are the functional units in protein translocation, consistent with the antiparallel dimeric SecA observed in X-ray structure (25) .
We have shown previously that SecA formed a ring-like structure upon interacting with anionic phospholipids by AFM (31) . We therefore examined the structures of SecAA in lipids. Interestingly, the ring-like pore structures of SecAA and SecA are remarkably similar in size and shape (Fig. 5) , implying that dimeric (or higher-order) lipid-bound SecA is the channelforming unit. These observations indicate that SecA exists in lipid bilayers likely as dimers, not monomers or tethered monomers; otherwise, one would expect to observe side-byside twin ring-like pore monomer structures in tandem dimerized SecA preparations.
These data indicate that it is not essential for SecA to dissociate into monomers to be functional. The possibility that only one of the protomers of the tandem SecA dimer is actively involved in translocation cannot be excluded. However, the complementation and in vivo cross-linking of inactive SecAL43P and SecAL826Q, the structure and function of SecAA tandem dimers, and the dimeric crystal structure of E. 5 . SecAA forms ring-like pore structures, like SecA, as observed by AFM. Purified SecA and SecAA were incubated with lipid bilayers prepared from extracted E. coli membrane lipids and mounted on freshly cleaved mica as previously described (31) . The lower panels represented three-dimensional structures.
